Ledger.Open graph →
SEC Form D · filed January 7, 2021

Werewolf Therapeutics, Inc

Offering
$72.1M
Sold
$72.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Sakae Asanuma · Cambridge, MADirectorBriggs Morrison · Cambridge, MADirectorDavid Cordo · Cambridge, MAExecLuke Evnin · Cambridge, MADirectorDaniel Hicklin · Cambridge, MAExec · DirectorAlon Lazarus · Cambridge, MADirectorDavid Cordo · Cambridge, MAExecRandal R. Betz · Bradenton, FLDirectorDale R. Whipple · Nashua, NHDirectorDrew Eldred · Boise, IDDirectorKyle Sale · Boise, IDDirectorArthur Dzaghgouni · Grand Cayman, Cayman IslandsExec · DirectorElise Wang · Foster City, CADirectorDerek Dirocco · South San Francisco, CADirectorMicah Johnson · Boise, IDExecPete Hartigan · San Francisco, CAExec · DirectorDavid R. Mchale · Wilton, CTDirectorMatthew J. Arciuolo · Wilton, CTDirectorRalph Woodford · Grand Cayman, Cayman IslandsDirectorBTG Pactual Consumer Asset Backed Investment GP, Ltd · Grand Cayman, Cayman IslandsDirectorElise Wang · Foster City, CADirectorDerek Dirocco · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗